These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 9797415)

  • 21. In vitro evaluation of ceftibuten (7432-S, SCH 39720), a novel orally administered cephalosporin.
    Jones RN; Barry AL
    Chemioterapia; 1988 Oct; 7(5):283-6. PubMed ID: 3147148
    [TBL] [Abstract][Full Text] [Related]  

  • 22. In vitro susceptibility of Helicobacter pylori to the new oral cephalosporins cefpodoxime, ceftibuten and cefixime.
    Westblom TU; Gudipati S; Midkiff BR
    Eur J Clin Microbiol Infect Dis; 1990 Sep; 9(9):691-3. PubMed ID: 2226500
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Clinical evaluation of cefixime in pediatric respiratory tract infections].
    Iwai N; Nakamura H; Kasai K; Ozaki T; Matsui Y; Tauchi N; Yamaguchi H; Taneda Y; Maki T
    Jpn J Antibiot; 1991 Jan; 44(1):35-47. PubMed ID: 2041146
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Antimicrobial activity and spectrum of ceftibuten (7432-S, SCH 39720)--a review of United States and Canadian results.
    Jones RN
    Diagn Microbiol Infect Dis; 1991; 14(1):37-43. PubMed ID: 2013209
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [In vitro effect of cefixime against Haemophilus influenzae].
    Dabernat H; Delmas C
    Presse Med; 1989 Oct; 18(32):1551-2. PubMed ID: 2530529
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Clinical evaluation of cefixime in children].
    Meguro H; Arimasu O; Sohda H; Yoshida J; Togasaki K; Fujii R
    Jpn J Antibiot; 1986 Apr; 39(4):1007-19. PubMed ID: 3761534
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Comparison of 5-day and 10-day cefixime in the treatment of acute exacerbation of chronic bronchitis.
    Lorenz J
    Chemotherapy; 1998 Sep; 44 Suppl 1():15-8. PubMed ID: 9797418
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Activity of FCE 22891 compared with cefuroxime axetil and cefixime in pulmonary and subcutaneous infections in mice.
    Rossi R; Castellani P; Younes G; Della Bruna C
    J Antimicrob Chemother; 1989 Mar; 23 Suppl C():149-55. PubMed ID: 2732136
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [In vitro comparative effect of cefixime and 7 other beta-lactamines against Streptococcus pneumoniae].
    Boussougant Y; Weber P
    Presse Med; 1989 Oct; 18(32):1553-5. PubMed ID: 2530530
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Bacteriological comparison of cefixime in patients with noncomplicated urinary tract infection in Spain. Preliminary results.
    García-Rodríguez JA
    Chemotherapy; 1998 Sep; 44 Suppl 1():28-30. PubMed ID: 9797421
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Third generation oral cephalosporins: comparative in vitro kinetics.
    Speciale A; Blandino G; Nicoletti G
    J Chemother; 1995 May; 7 Suppl 1():9-12. PubMed ID: 8618112
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Once-a-day therapy for sinusitis: a comparison study of cefixime and amoxicillin.
    Edelstein DR; Avner SE; Chow JM; Duerksen RL; Johnson J; Ronis M; Rybak LP; Bierman WC; Matthews BL; Kohlbrenner VM
    Laryngoscope; 1993 Jan; 103(1 Pt 1):33-41. PubMed ID: 8421417
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Comparison of roxithromycin with cefixime in the treatment of adults with community-acquired pneumonia.
    Salvarezza CR; Mingrone H; Fachinelli H; Kijanczuk S
    J Antimicrob Chemother; 1998 Mar; 41 Suppl B():75-80. PubMed ID: 9579717
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cefixime versus amoxicillin/clavulanic acid in lower respiratory tract infections.
    Beumer HM
    Int J Clin Pharmacol Ther Toxicol; 1989 Jan; 27(1):30-3. PubMed ID: 2663735
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Ceftibuten: minimal inhibitory concentrations, postantibiotic effect and beta-lactamase stability--a rationale for dosing programs.
    Neu HC
    Pediatr Infect Dis J; 1995 Jul; 14(7 Suppl):S88-92. PubMed ID: 7567316
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Serum bactericidal activity of newer oral cephalosporins in healthy volunteers.
    Dan M; Poch F; Edelman A; Asherov J; Hafely H; Atzmon Y
    J Antimicrob Chemother; 1998 Apr; 41(4):485-8. PubMed ID: 9598780
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Cefixime treatment in different bacterial infections in the ENT region].
    Schlenter WW; Blessing R; Pelz K; Benner U
    Infection; 1990; 18 Suppl 3():S125-8. PubMed ID: 2079371
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cefotaxime use in pediatric infections.
    Dajani AS
    Diagn Microbiol Infect Dis; 1995; 22(1-2):105-10. PubMed ID: 7587022
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Clinical efficacy and tolerability of cefixime in the treatment of acute sinusitis.
    Gehanno P; Boucot I; Berche P; Uhlrich J
    Drugs; 1991; 42 Suppl 4():19-24. PubMed ID: 1725150
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Determination of the antimicrobial susceptibilities of Canadian isolates of Haemophilus influenzae, Streptococcus pneumoniae and Moraxella catarrhalis. Canadian Antimicrobial Study Group.
    Blondeau JM; Suter M; Borsos S
    J Antimicrob Chemother; 1999 Mar; 43 Suppl A():25-30. PubMed ID: 10225568
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.